ES8404516A1 - Un procedimiento de dosificacion de las lipoproteinas de baja densidad (ldl) contenidas en los liquidos biologicos o en los extractos tisulares - Google Patents

Un procedimiento de dosificacion de las lipoproteinas de baja densidad (ldl) contenidas en los liquidos biologicos o en los extractos tisulares

Info

Publication number
ES8404516A1
ES8404516A1 ES524070A ES524070A ES8404516A1 ES 8404516 A1 ES8404516 A1 ES 8404516A1 ES 524070 A ES524070 A ES 524070A ES 524070 A ES524070 A ES 524070A ES 8404516 A1 ES8404516 A1 ES 8404516A1
Authority
ES
Spain
Prior art keywords
density lipoproteins
low density
ldl
quantification
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES524070A
Other languages
English (en)
Other versions
ES524070A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Publication of ES524070A0 publication Critical patent/ES524070A0/es
Publication of ES8404516A1 publication Critical patent/ES8404516A1/es
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE PRECIPITAN SELECTIVAMENTE LAS LIPOPROTEINAS (LDL) MEDIANTE TRATAMIENTO DE LOS LIQUIDOS BIOLOGICOS O DE LOS EXTRACTOS TISULARES CON UN REACTIVO QUE CONTIENE UNO O VARIOS POLIANIONES TALES COMO HEPARINA, POLIETILENGLICOLES, FOSFOWOLFRAMATOS, SULFATO DE DEXTRANO O ANALOGOS, CATIONICO O NO IONICO, PARA EVITAR LA PRECIPITACION CONCOMITANTE DE LAS LIPOPROTEINAS DE MUY BAJA DENSIDAD O DE LOS QUILOMICRONES; SEGUNDA, SE SEPARA EL PRECIPITADO POR CENTRIFUGACION LENTA; Y POR ULTIMO, SE DETERMINA LA CANTIDAD DE LDL PRECIPITANTEMEDIANTE UNA MEDIDA TURBIDIMETRICA O NEFELOMETRI
ES524070A 1981-09-28 1983-07-12 Un procedimiento de dosificacion de las lipoproteinas de baja densidad (ldl) contenidas en los liquidos biologicos o en los extractos tisulares Expired ES8404516A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8118220A FR2513766B1 (fr) 1981-09-28 1981-09-28 Procedes et reactifs de separation selective des lipoproteines de faible densite ldl et de quantification de leurs composants

Publications (2)

Publication Number Publication Date
ES524070A0 ES524070A0 (es) 1984-04-16
ES8404516A1 true ES8404516A1 (es) 1984-04-16

Family

ID=9262522

Family Applications (2)

Application Number Title Priority Date Filing Date
ES515987A Expired ES8400605A1 (es) 1981-09-28 1982-09-27 Un procedimiento de precipitacion selectiva de las lipoproteinas de baja densidad contenidas en los liquidos biologicos o en los extractos tisulares.
ES524070A Expired ES8404516A1 (es) 1981-09-28 1983-07-12 Un procedimiento de dosificacion de las lipoproteinas de baja densidad (ldl) contenidas en los liquidos biologicos o en los extractos tisulares

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES515987A Expired ES8400605A1 (es) 1981-09-28 1982-09-27 Un procedimiento de precipitacion selectiva de las lipoproteinas de baja densidad contenidas en los liquidos biologicos o en los extractos tisulares.

Country Status (5)

Country Link
EP (1) EP0076211B1 (es)
AT (1) ATE27495T1 (es)
DE (1) DE3276449D1 (es)
ES (2) ES8400605A1 (es)
FR (1) FR2513766B1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3323949A1 (de) * 1983-07-02 1985-01-03 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und mittel zur raschen und vollstaendigen beseitigung einer truebung in einer biologischen fluessigkeit
DE3533288A1 (de) * 1985-09-18 1987-03-26 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung von hdl-cholesterin im serum
JP2799835B2 (ja) * 1995-01-31 1998-09-21 第一化学薬品株式会社 コレステロールの定量方法
DE19505894A1 (de) * 1995-02-21 1996-08-22 Boehringer Mannheim Gmbh Verfahren und Reagenz zur spezifischen Bestimmung von LDL in Serumproben
JP3256241B2 (ja) * 1995-03-16 2002-02-12 協和メデックス株式会社 低密度リポ蛋白中のコレステロールの定量法
CN1148891A (zh) * 1995-03-20 1997-04-30 协和梅迪克斯株式会社 低密度脂蛋白中或极低密度脂蛋白中的胆甾醇的定量法
CA2360679A1 (en) * 1999-01-20 2000-07-27 Kazuhito Miyauchi Method for quantitating triglycerides in lipoproteins
EP1828783A1 (en) * 2004-12-01 2007-09-05 BioMerieux, Inc. Method for diagnosing critically ill patients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039285A (en) * 1975-10-10 1977-08-02 Ortho Diagnostics, Inc. Single sample method for determination of lipoprotein concentrations in blood
EP0006822B1 (fr) * 1978-07-04 1982-10-13 Laboratoires Goella Procédé et ensemble de réactifs pour le dosage du cholestérol sérique
DE2839433A1 (de) * 1978-09-11 1980-03-20 Merck Patent Gmbh Waessrige lipid-standardloesung und verfahren zu ihrer herstellung
US4215993A (en) * 1978-12-04 1980-08-05 Data Medical Associates, Inc. Precipitating reagent and method for isolation and determination of high density lipoproteins in human serum
GB2061282B (en) * 1979-10-22 1983-03-30 Symphar Sa Method for the clinical separation of a-and lipoproteins and kit for carrying out this method

Also Published As

Publication number Publication date
ES524070A0 (es) 1984-04-16
ATE27495T1 (de) 1987-06-15
EP0076211A3 (en) 1983-06-01
ES515987A0 (es) 1983-11-01
EP0076211B1 (fr) 1987-05-27
ES8400605A1 (es) 1983-11-01
EP0076211A2 (fr) 1983-04-06
FR2513766B1 (fr) 1985-09-13
FR2513766A1 (fr) 1983-04-01
DE3276449D1 (en) 1987-07-02

Similar Documents

Publication Publication Date Title
DK160881A (da) Fremgangsmaade til fremstilling af mikrokapsler i en flydende baerer
ES8706263A1 (es) Un metodo para diferenciar subclases de globulos blancos de la sangre
ES8404516A1 (es) Un procedimiento de dosificacion de las lipoproteinas de baja densidad (ldl) contenidas en los liquidos biologicos o en los extractos tisulares
JPS5542598A (en) Sugar refining method using emulsion anionic exchange resin
ES482205A1 (es) Metodo de medir colesterol del suero y perfeccionamientos en las disposiciones para su realizacion.
EP0367220A3 (en) Albumin preparation and process for preparing the same
ATE12699T1 (de) Reagens zur praezipitation apo-b-haltiger lipoproteine, verfahren zu dessen herstellung und dessen verwendung bei der bestimmung von hdl- cholesterin.
DE3568050D1 (en) New ionic fluorinated polymer, preparation process thereof and electrolysis membranes formed from said polymer
DE69023874D1 (de) Allgemeine Ätz-Stoppschichten aus Salzen von polyamischer Säure für reaktives ionisches Ätzen.
ATE212980T1 (de) Verfahren zur reinigung von dimethylsulfoxyd (dmso)
DE3572604D1 (en) Separation and recovery of solids from liquids using the ionic flotation process
ATE24733T1 (de) Polyaetherurethan-teilchen mit absorptionsvermoegen, verfahren zur herstellung von diesen polyaetherurethan-teilchen, sowie verfahren zur extraktion oder trennung von metallen aus fluessigkeiten unter verwendung dieser teilchen.
AU654778B2 (en) Process and reagent for the specific determination of LDL in serum samples
ATE72568T1 (de) Verfahren zur trennung von polypeptiden.
EP0404590A3 (en) Method of and reagent for the prevention of turbidity
ATA44082A (de) Verfahren zur aufbereitung von relativ reinem vorsortiertem altpapier, insbesondere abfallpapieren der papierfabrikation
EP0146904A3 (en) Composite thickening agent
ES8505380A1 (es) Procedimiento para separar lipoproteinas a partir de un liquido acuoso
EP0356858A3 (de) Verfahren zur Abtrennung von Cyclohexanol
BR8202530A (pt) Processo de determinacao na recepcao e em meio pertubado do estado de um sinal alternativo util total ou nulamente modulado circuito de recepcao e de determinacao
JPS6486872A (en) Method for separating glycan hydrolase
Bashaeva Modifying Pulp Ionic Composition as a Way of Improving Concentration of Lead--Zinc Ores With a High Slime Content
DE69006761D1 (de) Verfahren zur Trennung von Lösungsgemischen durch Elektrodialyse.
McGlothlin Cupola Banking and Meltdown Practices
Hamilton Instrument evaluation.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020401